Navigation Links
Roche responds to announcement of 'IDEAL' hepatitis C trial results
Date:1/14/2008

nical data and patient and physician preference. We are convinced that physicians and patients will continue to choose PEGASYS/ribavirin combination therapy based on positive experience and sound clinical evidence," said George Abercrombie, President and CEO, Hoffmann-La Roche. "Our current focus at Roche is on advancing the treatment of hepatitis C by optimizing doses and duration of PEGASYS/ribavirin in patients with unmet medical need, while developing new compounds that have the potential to offer a successful outcome to even more patients."

Roche believes that it is critical for patients and physicians to receive complete information to fully understand the results of "IDEAL," so that treatment decisions can be based on sound scientific data.

Please see below for additional information about the "IDEAL" trial, Roche and PEGASYS, including important safety information.

"IDEAL" Trial Design Issues

* Starting doses of ribavirin were different in the Peg-Intron and

PEGASYS arms of the study

* The design calls for a more drastic ribavirin dose reduction for side

effect management in most patients in the PEGASYS arm compared to

patients in the Peg-Intron arms; in some cases, ribavirin dose

reductions for patients in the PEGASYS arm were three times greater

than for patients in the Peg-Intron arms. This is important because a

substantial number of patients being treated for hepatitis C require

their ribavirin dose to be reduced to manage side effects, and this

could have an impact on the efficacy of the regimen

* The PEGASYS arm was not blinded, meaning that patients and physicians

knew which treatment was being administered. Many comparative studies

are blinded to ensure that bias does not compromise the results

* Erythropoetin (EPO) is a medication that is often given to treat

ribavirin-related anemia and help pat
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
2. Two Pivotal Phase III Studies for Roches ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms
3. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
4. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
5. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
6. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
9. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
10. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
11. Schering-Plough Reports Top-Line Results of the IDEAL Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 23, 2013  Ameritox, the nation,s leader ... Progressive Medical, Inc. to become part of its ... manage pharmacy costs and improve the clinical outcomes ... leading pharmacy benefit manager in the workers, compensation ... compliance and pain management strategy for several years. ...
(Date:5/23/2013)... 23, 2013  BioElectronics Corporation (OTC Pink: BIEL), the ... on the FDA panel meeting for non-thermal shortwave diathermy: ... Pulsed Shortwave Therapy Meeting was held on May 21, ... The focus of the meeting was very narrow, in ... solely on the application of non-thermal shortwave diathermy for ...
(Date:5/23/2013)... 23, 2013  CAS Medical Systems, Inc. (NASDAQ: ... patient monitoring, today announced that Thomas M. Patton ... the 2 nd Annual Marcum MicroCap Conference on Thursday, ... New York City . The presentation ... Estate 10 room and will be available via a live ...
Breaking Medicine Technology:Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 2Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 3BioElectronics and Pulsed Shortwave Therapy Make Progress 2CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2
... and Drug Administration (FDA) has recently issued safety alerts about ... contaminated nasal spray contact lenses that may cause eye ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... from health care professionals and the public through the agency,s ...
... 2011 Reportlinker.com announces that a ... in its catalogue: ... Market 2011-2021 ... the commercial prospects for lyophilisation technology? ...
Cached Medicine Technology:Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 2Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 3Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 4Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 5Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 6Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 7Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 8Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 9Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 10Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 11Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 12Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 13
(Date:5/25/2013)... May 25, 2013 HealthCrave Medical ... is unique in that it doesn’t just focus ... on treating what causes the noticeable signs of ... Dr. James D. Weiss, M.D., the center provides ... process while helping patients to live longer, healthier ...
(Date:5/24/2013)... A recent study by research group Harris ... upcoming bathing suit season. Almost 138 million people are fearful ... due to weight issues and a quarter admit they feel ... Labs recommends that those anxious about their size consider the ... of an overall effort to improve diet and exercise habits ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Compromise is often ... compromise when it comes to sleep and comfort. However, many ... prove highly individual. For some, this can cause added stress, ... mattress advice blog, tackles eight common issues in their latest ... Wants Soft, He Wants Firm: What to do When You ...
(Date:5/24/2013)... York (PRWEB) May 24, 2013 ... DePuy hip recall continue to move forward in courts ... to documents filed in California’s San Francisco Superior Court ... an expedited trial of her DePuy hip lawsuit is ... DePuy Orthopaedics, Inc., et al., No. CGC11508806; Calif. Super. ...
(Date:5/24/2013)... KC and Monica Craichy, Founders of Living ... oldest sons, Kyle and Austin Craichy, will be kiteboarding with ... professional kiteboarders. , KC Craichy said he is excited to ... together such that virtually everyone who planned to be involved ... boarders will meet at Matheson Hammock Park and Beach in ...
Breaking Medicine News(10 mins):Health News:Anti-Aging Center Offers Advanced Treatment that Controls the Aging Process from Within 2Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 2Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 3Health News:What’s The Best Bed Offers Mattress & Sleep Solutions for Opposite Couples 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 3Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 4Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 2Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 3
... ... , ... 2010 -- SunTrust Banks, Inc., one of the largest banking organizations in the US, ... compliance and risk management functions across the enterprise on a common GRC ...
... , ... 100,000 Institutions Benefit from Free Resources Offered via EBSCOhost® , ... (PRWEB) June 22, 2010 -- EBSCO ... more and more users are incorporating these free resources into their daily research routines. ...
... ... spread the word about HIV prevention. , ... Chicago, IL (PRWEB) June 22, 2010 -- STDTestExpress , a service dedicated ... free HIV test with the purchase of an 8 Test Panel – a savings of $50. ...
... to ,failed inductions, researchers find , TUESDAY, June 22 ... risk of having a cesarean delivery, according to a ... link that experts have long suspected. , "Induction of ... Dr. Deborah Ehrenthal, director of women,s health programs at ...
... ... shares seven practices for complete wellness in her new book Wellness on a Shoestring. ... (PRWEB) June 22, 2010 -- ... exercise, skip the fast food. Ask if they’re doing those things regularly, and the response ...
... ... for the sun. , ... Jersey (PRWEB) June 22, 2010 -- With summer fast approaching, GlassesUSA.com is helping people ... store is offering past and potential customers a discount on their prescription sunglasses ...
Cached Medicine News:Health News:MetricStream Selected by SunTrust for Enterprise-Wide GRC 2Health News:MetricStream Selected by SunTrust for Enterprise-Wide GRC 3Health News:Free Resources from EBSCO Publishing Providing Useful Information to Researchers 2Health News:Free Resources from EBSCO Publishing Providing Useful Information to Researchers 3Health News:Free Resources from EBSCO Publishing Providing Useful Information to Researchers 4Health News:STDTestExpress Highlights National HIV Testing Day with Free HIV Testing 2Health News:STDTestExpress Highlights National HIV Testing Day with Free HIV Testing 3Health News:Labor Induction May Boost C-Section Risk 2Health News:Labor Induction May Boost C-Section Risk 3Health News:New Book Offers Seven Low-Cost Habits for a Healthier, Happier Life 2Health News:New Book Offers Seven Low-Cost Habits for a Healthier, Happier Life 3Health News:New Book Offers Seven Low-Cost Habits for a Healthier, Happier Life 4Health News:GlassesUSA.com Announces Sale on Prescription Sunglasses 2
The MICROsed-System is the ideal system back up support to be used as front-line instrument with small workloads....
Blood sedimentation rate analysis...
... The ESR-100 is an automated 100-position ESR ... 50 samples daily. The instrument accurately and ... in 1.2ml or 2.0ml ESR-Vacuum Tubes. Results ... Westergren Method) and are available in 30 ...
... The ESR-Auto Plus is an automated ... precisely measures the sedimentation rate of erythrocytes ... in millimeters per hour (Modified Westergren Method) ... instrument features random access, a built-in printer, ...
Medicine Products: